The benefits of using diverse animal models for studying pertussis
- PMID: 17920273
- DOI: 10.1016/j.tim.2007.09.003
The benefits of using diverse animal models for studying pertussis
Abstract
Pertussis, a respiratory disease caused by infection with Bordetella pertussis, represents one of the most devastating diseases in infants and young children worldwide. Significant research efforts over the last five decades have led to the introduction of two types of vaccines, which are now available worldwide and which have significantly reduced the global incidence of pertussis. The use of animal models and, in particular, the mouse model has benefited in the development of these vaccines tremendously. However, open questions regarding the duration of immunity, the type of immune response needed for protection and the role of mucosal and innate immunity in disease protection still remain. Here, we review the various animal models available currently and their benefits for studying this important disease.
Similar articles
-
A new animal model of Bordetella pertussis infection and immunity.Trends Microbiol. 2005 Dec;13(12):559-60. doi: 10.1016/j.tim.2005.09.007. Epub 2005 Oct 11. Trends Microbiol. 2005. PMID: 16223585
-
Mouse and pig models for studies of natural and vaccine-induced immunity to Bordetella pertussis.J Infect Dis. 2014 Apr 1;209 Suppl 1:S16-9. doi: 10.1093/infdis/jit488. J Infect Dis. 2014. PMID: 24626866 Review.
-
The cellular immune response to Bordetella pertussis in two children with whooping cough.Eur J Med Res. 1998 Nov 17;3(11):523-6. Eur J Med Res. 1998. PMID: 9810032
-
Experimental models for testing "Bordetella pertussis" virulence and immunogenicity.Ann Sclavo Collana Monogr. 1986;3(1-2):319-27. Ann Sclavo Collana Monogr. 1986. PMID: 2892512 No abstract available.
-
Resurgence of pertussis calls for re-evaluation of pertussis animal models.Expert Rev Vaccines. 2012 Sep;11(9):1121-37. doi: 10.1586/erv.12.83. Expert Rev Vaccines. 2012. PMID: 23151168 Review.
Cited by
-
Reactivating Immunity Primed by Acellular Pertussis Vaccines in the Absence of Circulating Antibodies: Enhanced Bacterial Control by TLR9 Rather Than TLR4 Agonist-Including Formulation.Front Immunol. 2019 Jul 3;10:1520. doi: 10.3389/fimmu.2019.01520. eCollection 2019. Front Immunol. 2019. PMID: 31333656 Free PMC article.
-
Screening and Genomic Characterization of Filamentous Hemagglutinin-Deficient Bordetella pertussis.Infect Immun. 2018 Mar 22;86(4):e00869-17. doi: 10.1128/IAI.00869-17. Print 2018 Apr. Infect Immun. 2018. PMID: 29358336 Free PMC article.
-
Complete Genome Sequence of Bordetella pertussis D420.Genome Announc. 2015 Jun 11;3(3):e00657-15. doi: 10.1128/genomeA.00657-15. Genome Announc. 2015. PMID: 26067980 Free PMC article.
-
Investigating Bordetella pertussis colonisation and immunity: protocol for an inpatient controlled human infection model.BMJ Open. 2017 Oct 11;7(10):e018594. doi: 10.1136/bmjopen-2017-018594. BMJ Open. 2017. PMID: 29025851 Free PMC article.
-
Airborne transmission of Bordetella pertussis.J Infect Dis. 2012 Sep 15;206(6):902-6. doi: 10.1093/infdis/jis443. Epub 2012 Jul 17. J Infect Dis. 2012. PMID: 22807521 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical